GlassScriptPhysician profile
Gordon Howard Hutt
NPI 1952392987
$5,474.01
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $906 · 2020: $1,016 · 2021: $1,344 · 2022: $1,217 · 2023: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,553.20 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $751.72 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $535.04 | 2020-2022 | |
| Amgen INC. | $529.94 | 2019-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $420.78 | 2019-2023 | Jardiance |
| Pfizer INC. | $217.43 | 2019-2023 | |
| Esperion Therapeutics, INC. | $211.08 | 2020-2023 | Nexletol |
| Merck Sharp & Dohme LLC | $196.10 | 2021-2023 | Verquvo |
| Novo Nordisk INC | $188.02 | 2019-2023 | Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $162.05 | 2019-2023 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $122.68 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $95.42 | 2019-2022 | |
| Amarin Pharma, INC. | $89.07 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $83.12 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $80.79 | 2023 | Optimizer |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $62.53 | 2022-2023 | Flexitouch Plus, Entre Plus |
| Medtronic Vascular, INC. | $47.68 | 2019 | |
| Abbott Laboratories | $40.80 | 2021 | |
| Kestra Medical Technology Services, INC. | $33.26 | 2023 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $14.55 | 2023 | Inpefa |
| Boston Scientific Corporation | $14.11 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Medtronic, INC. | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Hutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.